Clinical Trial Update: Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor [Phase 4]

View source ↗

Summary

A Phase 4 open-label randomized trial compared starting lopinavir/ritonavir monotherapy versus triple therapy with a boosted protease inhibitor in HIV-infected …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Sociedad Andaluza de Enfermedades Infecciosas | Conditions: HIV Infection | Phase 4 | Status: COMPLETED